From: Management and outcomes of side effects with focus on anaemia in patients with hepatitis C genotype 1 infection: the telaprevir early access program in patients from Romania
Type of anaemia
Definition
Total (n=209)
Grade 1-2
Hb 9-10.9 or 2.5-4.4 g/dL decrease
33 (16%)
Grade 3-4
Hb <8.9 or >4.5 g/dL decrease
86 (41%)
D/C for anaemia
1 (<1%)
Anaemia as Serious AE
9 (4%)